Literature DB >> 16850156

Fibrosis in non-cancerous tissue is the unique prognostic factor for primary hepatocellular carcinoma without hepatitis B or C viral infection.

Yoshito Tomimaru1, Yo Sasaki, Terumasa Yamada, Hidetoshi Eguchi, Hiroaki Ohigashi, Osamu Ishikawa, Shingi Imaoka.   

Abstract

BACKGROUND: The relationship between the state of non-cancerous tissues in patients with hepatocellular carcinoma (HCC) who are negative for hepatitis B surface antigen (HBsAg), hepatitis B core antibody (HBcAb), and hepatitis C antibody (HCVAb) (NBNC-HCC) and the prognosis has not yet been resolved.
METHODS: We examined the clinicopathological features of these patients and performed statistical analysis for the prognosis of recurrence following curative hepatic resection.
RESULTS: Disease-free survival (DFS) revealed that only the degree of fibrosis was a significant prognostic factor (P = 0.0374). On the basis of the degree of fibrosis (New Inuyama Classification), patients with NBNC-HCC were divided into a non-fibrotic liver group (NF group; F0, n = 10) and a fibrotic liver group (FL group; F1-4, n = 34). The DFS rate in the NF group was significantly better than that in the FL group (P = 0.0408). In the NF group, only one patient recurred, while in the FL group, 21 patients had recurrences. In the FL group, intra-hepatic recurrence was frequently seen in both lobes within 2 years after the initial hepatic resection, while recurrences more than 2 years after the initial operation were mainly seen in the contralateral lobe.
CONCLUSION: Histological assessment of the degree of fibrosis in the non-cancerous regions of NBNC-HCC may be useful not only for the selection of the appropriate treatment but also for the prediction of postoperative prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16850156     DOI: 10.1007/s00268-005-0123-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index.

Authors:  Gregory Y Lauwers; Benoit Terris; Ulysses J Balis; Kenneth P Batts; Jean-Marc Regimbeau; Yuchiao Chang; Fiona Graeme-Cook; Hirohiko Yamabe; Iwao Ikai; Karen R Cleary; Shiro Fujita; Jean-Francois Flejou; Lawrence R Zukerberg; David M Nagorney; Jacques Belghiti; Yoshio Yamaoka; Jean-Nicolas Vauthey
Journal:  Am J Surg Pathol       Date:  2002-01       Impact factor: 6.394

2.  Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma.

Authors:  N Yamanaka; T Tanaka; W Tanaka; J Yamanaka; C Yasui; N Kuroda; M Takada; E Okamoto
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

3.  The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver.

Authors:  M Shimada; T Rikimaru; K Sugimachi; T Hamatsu; Y Yamashita; S Aishima; K Taguchi; S Tanaka; K Shirabe; K Sugimachi
Journal:  J Am Coll Surg       Date:  2000-11       Impact factor: 6.113

4.  Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma.

Authors:  M M Bilimoria; G Y Lauwers; D A Doherty; D M Nagorney; J Belghiti; K A Do; J M Regimbeau; L M Ellis; S A Curley; I Ikai; Y Yamaoka; J N Vauthey
Journal:  Arch Surg       Date:  2001-05

5.  Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.

Authors:  S Takano; O Yokosuka; F Imazeki; M Tagawa; M Omata
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

6.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.

Authors:  K Ikeda; S Saitoh; I Koida; Y Arase; A Tsubota; K Chayama; H Kumada; M Kawanishi
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

7.  Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.

Authors:  E Adachi; T Maeda; K Kajiyama; N Kinukawa; T Matsumata; K Sugimachi; M Tsuneyoshi
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

8.  A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use.

Authors:  N Yamanaka; E Okamoto; T Oriyama; J Fujimoto; K Furukawa; E Kawamura; T Tanaka; F Tomoda
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

9.  Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients.

Authors:  U C Nzeako; Z D Goodman; K G Ishak
Journal:  Am J Clin Pathol       Date:  1996-01       Impact factor: 2.493

10.  Clinical features of patients with HCC who are negative for both HBV and HCV markers.

Authors:  Hirotsugu Watabe; Yasushi Shiratori; Ryousuke Tateishi; Tomonori Fujishima; Masatoshi Akamatsu; Yukihiro Koike; Shuntaro Obi; Keisuke Hamamura; Shinpei Sato; Takuma Teratani; Shuichiro Shiina; Masao Omata
Journal:  Hepatogastroenterology       Date:  2003 Nov-Dec
View more
  4 in total

1.  Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Akira Miki; Yukiko Morinaga; Tomoo Itoh; Masaru Yoshida; Takeshi Azuma
Journal:  Clin J Gastroenterol       Date:  2012-02-18

2.  Development of a novel rat model of heterogeneous hepatic injury by injection with colchicine via the splenic vein.

Authors:  Yan-Yan Zhang; Chao-Xu Zhang; Yu Li; Xuan Jiang; Yong-Fang Wang; Yang Sun; Jun Wang; Wan-Ying Ji; Yi Liu
Journal:  World J Gastroenterol       Date:  2018-11-28       Impact factor: 5.742

3.  Short-term outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma in older patients: a propensity score matching analysis.

Authors:  Kazuteru Monden; Hiroshi Sadamori; Masayoshi Hioki; Satoshi Ohno; Norihisa Takakura
Journal:  BMC Surg       Date:  2022-02-23       Impact factor: 2.102

4.  MR Prediction of Liver Function and Pathology Using Gd-EOB-DTPA: Effect of Liver Volume Consideration.

Authors:  Dai Shimamoto; Akihiro Nishie; Yoshiki Asayama; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Ken Shirabe; Tomoyuki Hida; Yuichiro Kubo; Hiroshi Honda
Journal:  Biomed Res Int       Date:  2015-11-01       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.